CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,662,139
- in 5 filings, $21.7M under 10b5-1 plans
Net −$21,662,139. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-19 | Torley Helen PRESIDENT AND CEO | Sale | −10,000 | $52.41 | $524K | 587,177 |
| 2023-01-19 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock | −10,000 | $14.66 | $147K | 60,000 |
| 2023-01-18 | Torley Helen PRESIDENT AND CEO | Exercise or conversion | +10,000 | $14.66 | $147K | 597,177 |
| 2023-01-18 | Torley Helen PRESIDENT AND CEO | Sale | −10,000 | $51.05 | $510K | 587,177 |
| 2023-01-18 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock | −10,000 | $14.66 | $147K | 70,000 |
| 2023-01-17 | Torley Helen PRESIDENT AND CEO | Exercise or conversion | +10,000 | $14.66 | $147K | 597,177 |
| 2023-01-17 | Torley Helen PRESIDENT AND CEO | Sale | −8,897 | $50.40 | $448K | 588,280 |
| 2023-01-17 | Torley Helen PRESIDENT AND CEO | Sale | −1,103 | $50.93 | $56K | 587,177 |
| 2023-01-17 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock | −10,000 | $14.66 | $147K | 80,000 |
| 2023-01-17 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale | −8,878 | $50.40 | $447K | 144,259 |
| 2023-01-17 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale | −1,122 | $50.93 | $57K | 143,137 |
| 2023-01-03 | Snyder Mark Howard SVP, GENERAL COUNSEL | Exercise or conversion | +7,611 | 7,611 | ||
| 2023-01-03 | Snyder Mark Howard SVP, GENERAL COUNSEL | Shares withheld for taxes | −2,804 | $55.13 | $155K | 4,807 |
| 2023-01-03 | Snyder Mark Howard SVP, GENERAL COUNSEL | Exercise or conversion · Restricted Stock Units | −7,611 | 22,833 | ||
| 2022-12-15 | Torley Helen PRESIDENT AND CEO | Exercise or conversion | +10,000 | $14.66 | $147K | 597,177 |
| 2022-12-15 | Torley Helen PRESIDENT AND CEO | Sale | −9,104 | $57.29 | $522K | 588,073 |
| 2022-12-15 | Torley Helen PRESIDENT AND CEO | Sale | −896 | $58.20 | $52K | 587,177 |
| 2022-12-15 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock | −10,000 | $14.66 | $147K | 90,000 |
| 2022-12-14 | Torley Helen PRESIDENT AND CEO | Exercise or conversion | +10,000 | $14.66 | $147K | 597,177 |
| 2022-12-14 | Torley Helen PRESIDENT AND CEO | Sale | −10,000 | $58.30 | $583K | 587,177 |
Page 43 of 48 · 944 trades